Its important to note that while GLP-1s have been used in diabetes care for years, their widespread use for weight loss is relatively new
DAC and Duration of Action The biggest mechanistic distinction within the CJC-1295 category is DAC status
What keeps it at a 7: the "2 inches" headline is the best case, not the average (the real trial was small and the typical effect modest), it only helps food-related bloating (not IBS, hormonal, SIBO or garlic/onion triggers), and it's a with-every-meal routine
By focusing on certain foods and nutrients, one can support their bodys glutathione production and maintenance
An important consideration is that GLP-1 receptor agonists delay gastric emptying and intestinal transit (Meloni et al
Seven additional Phase 3 trials are expected to complete in 2026